company background image
XRAY logo

DENTSPLY SIRONA NasdaqGS:XRAY Rapport sur les actions

Dernier prix

US$18.52

Capitalisation boursière

US$3.8b

7D

6.7%

1Y

-40.9%

Mise à jour

20 Nov, 2024

Données

Finances de l'entreprise +

DENTSPLY SIRONA Inc.

NasdaqGS:XRAY Rapport sur les actions

Capitalisation boursière : US$3.8b

XRAY Aperçu des actions

DENTSPLY SIRONA Inc. fabrique et vend divers produits et technologies dentaires dans le monde entier. Plus de détails

XRAY analyse fondamentale
Score flocon de neige
Évaluation5/6
Croissance future3/6
Performances passées0/6
Santé financière3/6
Dividendes4/6

DENTSPLY SIRONA Inc. Concurrents

Historique des prix et performances

Résumé des plus hauts, des changements et des baisses de prix pour DENTSPLY SIRONA
Historique des cours de bourse
Prix actuel de l'actionUS$18.52
Plus haut sur 52 semainesUS$37.60
Plus bas sur 52 semainesUS$17.21
Bêta1.03
1Variation sur 1 mois-24.19%
Variation sur 3 mois-23.28%
Variation sur 1 an-40.94%
3Variation sur 3 ans-63.87%
Variation sur 5 ans-67.57%
Évolution depuis l'introduction en bourse2,553.61%

Nouvelles et mises à jour récentes

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Recent updates

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

Nov 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive After Falling 27% But Perhaps Not Attractive Enough

DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

Oct 13
DENTSPLY SIRONA (NASDAQ:XRAY) Hasn't Managed To Accelerate Its Returns

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Sep 25
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Looks Inexpensive But Perhaps Not Attractive Enough

Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Sep 05
Is It Time To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Aug 18
Is There An Opportunity With DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) 21% Undervaluation?

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

Jul 11
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Have Hit The Brakes

A Tough Macro Environment Makes Dentsply Sirona's Turnaround Even Harder

Jul 02

Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

Jun 11
Insufficient Growth At DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Hampers Share Price

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

May 24
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona: I'm Buying The Pullback In This Medtech Leader

Apr 24

Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

Apr 22
Are Investors Undervaluing DENTSPLY SIRONA Inc. (NASDAQ:XRAY) By 47%?

There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Mar 10
There's No Escaping DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Muted Revenues

Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

Feb 16
Here's Why DENTSPLY SIRONA (NASDAQ:XRAY) Has A Meaningful Debt Burden

DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

Jan 29
DENTSPLY SIRONA (NASDAQ:XRAY) Has More To Do To Multiply In Value Going Forward

DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Jan 11
DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Shares Could Be 28% Below Their Intrinsic Value Estimate

Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Nov 25
Is It Too Late To Consider Buying DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Nov 06
These 4 Measures Indicate That DENTSPLY SIRONA (NASDAQ:XRAY) Is Using Debt Extensively

Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

Oct 15
Returns On Capital At DENTSPLY SIRONA (NASDAQ:XRAY) Paint A Concerning Picture

An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

Sep 18
An Intrinsic Calculation For DENTSPLY SIRONA Inc. (NASDAQ:XRAY) Suggests It's 46% Undervalued

DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

Jul 31
DENTSPLY SIRONA (NASDAQ:XRAY) Has A Pretty Healthy Balance Sheet

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Jul 09
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Jun 20
A Look At The Fair Value Of DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Jun 02
When Should You Buy DENTSPLY SIRONA Inc. (NASDAQ:XRAY)?

Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

May 15
Investors Don't See Light At End Of DENTSPLY SIRONA Inc.'s (NASDAQ:XRAY) Tunnel

The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Apr 05
The Returns At DENTSPLY SIRONA (NASDAQ:XRAY) Aren't Growing

Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

Mar 07
Is DENTSPLY SIRONA (NASDAQ:XRAY) Using Too Much Debt?

We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Nov 09
We Think DENTSPLY SIRONA (NASDAQ:XRAY) Can Stay On Top Of Its Debt

Dentsply Sirona names Glenn Coleman as new CFO

Sep 22

Dentsply Sirona hires Simon Campion as president, CEO

Aug 25

Dentsply Sirona receives noncompliance notice from Nasdaq

Aug 16

Dentsply Sirona: Weakening Fundamentals Outweigh 'Defensives' Argument

Jul 18

Rendement pour les actionnaires

XRAYUS Medical EquipmentUS Marché
7D6.7%-0.4%-1.0%
1Y-40.9%20.3%30.3%

Rendement vs Industrie: XRAY a sous-performé le secteur US Medical Equipment qui a rapporté 20.3 % au cours de l'année écoulée.

Rendement vs marché: XRAY a sous-performé le marché US qui a rapporté 30.3 % au cours de l'année écoulée.

Volatilité des prix

Is XRAY's price volatile compared to industry and market?
XRAY volatility
XRAY Average Weekly Movement8.9%
Medical Equipment Industry Average Movement8.2%
Market Average Movement6.2%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market3.1%

Cours de l'action stable: XRAY n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.

Volatilité au fil du temps: La volatilité hebdomadaire de XRAY ( 9% ) est restée stable au cours de l'année écoulée.

À propos de l'entreprise

FondéeSalariésPDGSite web
187715,000Simon Campionwww.dentsplysirona.com

DENTSPLY SIRONA Inc. fabrique et vend divers produits et technologies dentaires dans le monde entier. Elle opère dans quatre secteurs : Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions et Wellspect Healthcare. La société propose des équipements dentaires comprenant des équipements d'imagerie, des pièces à main dentaires motorisées, des centres de traitement, d'autres instruments, des amalgameurs, des mélangeurs et des fours à porcelaine, ainsi que des technologies de CAO/FAO dentaires pour soutenir les restaurations dentaires, telles que des scanners intra-oraux, des imprimantes 3D, des fraises, d'autres logiciels et services, et une restauration économique complète de la dentisterie esthétique en céramique, ainsi que DS Core, sa plateforme basée sur le cloud computing.

DENTSPLY SIRONA Inc. Résumé des fondamentaux

Comment les bénéfices et les revenus de DENTSPLY SIRONA se comparent-ils à sa capitalisation boursière ?
XRAY statistiques fondamentales
Capitalisation boursièreUS$3.75b
Bénéfices(TTM)-US$413.00m
Recettes(TTM)US$3.90b

0.9x

Ratio P/S

-8.9x

Ratio P/E

Le site XRAY est-il surévalué ?

Voir Juste valeur et analyse de l'évaluation

Bénéfices et recettes

Principales statistiques de rentabilité tirées du dernier rapport sur les bénéfices (TTM)
XRAY compte de résultat (TTM)
RecettesUS$3.90b
Coût des recettesUS$1.87b
Marge bruteUS$2.04b
Autres dépensesUS$2.45b
Les revenus-US$413.00m

Derniers bénéfices déclarés

Sep 30, 2024

Prochaine date de publication des résultats

s/o

Résultat par action (EPS)-2.08
Marge brute52.18%
Marge bénéficiaire nette-10.59%
Ratio dettes/capitaux propres89.7%

Quelles ont été les performances à long terme de XRAY?

Voir les performances historiques et les comparaisons

Dividendes

3.5%

Rendement actuel des dividendes

-31%

Ratio de distribution